CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department
Abstract Introduction Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension. Methods Multicenter randomized clinical trial. Eligible patients had 2 systolic blood pres...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | 英語 |
| 出版事項: |
2011
|
| オンライン･アクセス: | https://doi.org/10.1186/cc10289 https://ccforum.biomedcentral.com/counter/pdf/10.1186/cc10289 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|